Evidence map›Paper›PMID 27812015›Full record

ArticleScientific reports2016

Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei.

Bhaskar Das, Md Imran Khan, R Jayabalan, Susanta K Behera, Soon-Il Yun, Suraj K Tripathy, Amrita Mishra

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Zinc oxide nanoparticles againstFrontiers in antibiotics · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A comprehensive review on potential applications of metallic nanoparticles as antifungal therapies to combat human fungal diseases.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Bhaskar DasSchool of Biotechnology, KIIT University, Bhubaneswar 751024, India.
Md Imran KhanSchool of Biotechnology, KIIT University, Bhubaneswar 751024, India.
R JayabalanDepartment of Life Sciences, National Institute of Technology, Rourkela 6150, India.
Susanta K BeheraIMGENEX India Pvt. Ltd., Bhubaneswar 751024, India.
Soon-Il YunDepartment of Food Science &Technology, Chonbuk National University, Jeonju 561756, South Korea.
Suraj K TripathySchool of Biotechnology, KIIT University, Bhubaneswar 751024, India.
Amrita MishraSchool of Biotechnology, KIIT University, Bhubaneswar 751024, India.
KIIT University · INIMGENEX India (India) · INJeonbuk National University · KRNational Institute of Technology Rourkela · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present paper, facile synthesis of Ag@ZnO core-shell nanocomposites is reported where zinc oxide is coated on biogenic silver nanoparticles synthesized using Andrographis paniculata and Aloe vera leaf extract. Structural features of as synthesized nanocomposites are characterized by UV-visible spectroscopy, XRD, and FTIR. Morphology of the above core-shell nanocomposites is investigated by electron microscopy. As synthesized nanocomposite material has shown antimicrobial activity against Candida krusei, which is an opportunistic pathogen known to cause candidemia. The possible mode of activity of the above material has been studied by in-vitro molecular techniques. Our investigations have shown that surface coating of biogenic silver nanoparticles by zinc oxide has increased its antimicrobial efficiency against Candida krusei, while decreasing its toxicity towards A431 human epidermoid carcinoma cell lines.

Indexed as

AloeAndrographisAntifungal AgentsCandidaCell Line, TumorCell SurvivalGreen Chemistry TechnologyHumansMetal NanoparticlesMicroscopy, ElectronMicroscopy, Electron, TransmissionNanocompositesParticle SizePlant LeavesReactive Oxygen SpeciesSilverAntifungal AgentsReactive Oxygen SpeciesSilverZinc Oxide

Identifiers

PMID27812015
PMCPMC5095647
OpenAlexW2546722221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.